KLRC2 and COVID-19: However, the presence of the NKG2C+ NK lymphocytes in recovered COVID-19 patients may suggest long-term impact of SARS-CoV-2 infection on NK cells, with a subpopulation that potentially suspend antiviral activity and acquire an adaptive profile.